• Insulin-releasing human pancreatic beta cell lines (D002)

  • Researchers at Ulster University have developed a number of insulin-secreting human β-cell lines. The cells are available for licence as highly functional research tools such as for diabetes drug ...

  • Read more
  • Toxin independent biomarker for detection of clostridium difficile (U245)

  • Ulster University have developed and clinically validated a novel Clostridium difficile (C. difficile) diagnostic test.  The “Ulster C. difficile Assay” is a rapid in vitro diagnostic test for ...

  • Read more
  • Glucose-responsive insulin secreting BRIN-BD11 cell line (U281)

  • Scientists at Ulster University in Northern Ireland have developed a number of rodent insulin-secreting human pancreatic β-cell lines. The cells are available for licence as highly functional ...

  • Read more
  • Energy Supply System for High Powered Medical Implants

  • There has been a remarkable development of medical devices over the last 30 years to support, and even substitute the heart in patients with advanced hear failure. However a clinically viable ...

  • Read more
  • RegenaGraft: Functional Bio Prosthetic Scaffolds

  • Bio-Scaffolds that can mimic the extracellular environment; encouraging cellular organisation and tissue function are essential for the future development of tissue engineering and regenerative ...

  • Read more
  • Leak Detection System for Ostomy Management

  • The creation of a stoma, an opening from the inside of an organ to the outside, is an increasingly common surgical intervention in the management of a large variety of clinical conditions. In ...

  • Read more
  • IdentiGait: Biometric Surveillance Solution based on Gait Identification

  • Normally surveillance involves the monitoring of behavior and activities of humans.  Biometric systems are technologies which measure and analyze human physical and/or behavioral characteristics ...

  • Read more
  • HistorySpace

  • The location-based mobile application solution developed by the team at the Centre for Media Research, is known as History Space: Downhill Demesne, and is available for free, from both the Apple ...

  • Read more
  • ANALYSE - systemAtic aNALYsiS Ecg

  • The recording of 12 lead electrocardiograms (ECG) continues to be one of the most useful and commonly performed medical procedures.  It is used in diagnosis, risk-stratification management ...

  • Read more
  • Therapeutic interventions via monitoring of life style behavioural profiles to support independent living using assisted technology for people with dementia at nighttime

  • The proposed Nocturnal Care system monitors user’s life style and behavioural profiles including sleeping and its related activities. According to individual’s behavioural profile, abnormal ...

  • Read more
  • Novel Apelin Receptor Agonists Provide for Improved Metabolic Control and Weight Loss (U370)

  • Researchers in the Biomedical Sciences Research Institute at Ulster University have demonstrated that synthetically derived analogues of apelin-13 improve metabolic status and reduce body weight ...

  • Read more
  • Predictive Biomarker of Pre-Diabetes and Type II Diabetes (D003)

  • Researchers from the Biomedical Sciences Research Institute at Ulster University have discovered a novel biomarker for predicting early on-set on diabetes in the form of glycated insulin.

  • Read more
  • Novel treatments for Alzheimer’s disease (AD) using stable analogues of GIP (U140A)

  • Ulster researchers within Ulster’s Biomedical Sciences Research Institute, has recently carried out proof of concept studies aimed at advancing a potential new class of molecules for treatment of ...

  • Read more
  • Novel Treatment of Alzheimer’s Disease Utilising GLP-1 (U140B)

  • University Researchers have developed a proprietary approach that addresses the treatment of Alzheimer’s Disease (AD) and other neurological disorders through a mechanism of action differentiated ...

  • Read more
  • Xenin-25, a promising new preclinical candidate for neurodegenerative diseases (U515)

  •  Preclinical research stemming from Ulster’s Diabetes Research Group has led to the development of a potentially new class of molecules for treatment of neurodegenerative disorders, in ...

  • Read more
  • Novel G-Protein Coupled Receptor Therapeutic Target and Related Agonists for Treatment of Type 2 Diabetes (U452)

  • Ulster University researchers from the Biomedical Sciences Research Institute have identified a G-Protein Coupled Receptor (GPCR) codified as GPRa1 in the pancreas and have demonstrated a key ...

  • Read more
  • Novel Amphibian Skin Peptides for Treatment of Diabetes (U366)

  • Researchers at Ulster University are internationally known for their expertise in the discovery and development of natural product-based peptides for diabetes. Such underpinning research has led ...

  • Read more
  • Stable Analogues of Xenin-25 as Promising Anti-Diabetic Therapies (U318)

  • Ulster University researchers at the Biomedical Sciences Research Institute have identified xenin analogues having a novel mechanism of action with a direct effect on β-cells to release ...

  • Read more
  • Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles (U537)

  • Scientists at Ulster University and University of Oxford have made a major breakthrough in the global fight against pancreatic cancer, the fourth most common cause of cancer-related deaths ...

  • Read more
  • Wound Hydrogel for Effective Drug Delivery and Anaesthesia of Acute and Chronic Wounds (Jenarron Therapeutics)

  •  Jenarron Therapeutics has developed a novel wound hydrogel that can be used to deliver soluble drug substances to all types of wounds, such as deep lacerations and chronic ulcers.  The material ...

  • Read more
  • A Novel GIP/Xenin Hybrid Peptide for Type 2 Diabetes (U511)

  • Type 2 diabetes is a major health concern and current standard-of-care includes secretagogues, sensitizers and more recently, mimics of proteins that interact with insulin.
    Type 2 diabetes is ...
  • Read more